Noxxon Pharma AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
September 2018
29
About the Report
About the Report
Summary
Noxxon Pharma AG (Noxxon) is a clinical stage biotechnology company that develops and provides drugs for the treatment of cancer. The company develops therapeutics for the treatment of inflammatory diseases and hematological disorders, diabetes and renal diseases, oncology, inflammation and pain. Its pipeline products include NOX-A12, used for the treatment of metastatic pancreatic and colorectal cancer, glioblastoma, multiple myeloma, and chronic lymphocyctic leukemia; and NOX-E36 for solid tumors. Noxxon's spiegelmer technology platform offers discovery capacities to generate additional leads under preclinical investigation. The company operates through academic investigators, and biotechnology and pharmaceutical companies. Noxxon is headquartered in Berlin, Germany.
Noxxon Pharma AG-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Noxxon Pharma AG, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Noxxon Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Noxxon Pharma AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Noxxon Pharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Noxxon Pharma AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Noxxon Pharma AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Noxxon Pharma AG, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Noxxon Pharma Enters into Agreement with National Center for Tumor Diseases 10
NOXXON Pharma Enters into Agreement with Merck 11
Licensing Agreements 12
Aptarion biotech Enters into Licensing Agreement with Noxxon Pharma 12
Equity Offering 13
Noxxon Pharma Raises USD1 Million in Private Placement of Shares 13
Debt Offering 14
Noxxon Pharma Raises USD0.4 Million in Private Placement of 7% Bond 14
Noxxon Pharma Raises USD0.6 Million in Fourth Tranche Private Placement of Bonds 15
Noxxon Pharma Raises USD0.5 Million in Third Tranche Private Placement of Bonds 16
Noxxon Pharma Raises USD0.6 Million in Second Tranche Private Placement of Bonds 17
Noxxon Pharma Raises USD1 Million in Public offering of Bonds 18
Noxxon Pharma Raises USD11 Million in Private Placement of Bonds 19
Noxxon Pharma AG-Key Competitors 20
Noxxon Pharma AG-Key Employees 21
Noxxon Pharma AG-Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Apr 30, 2018: NOXXON Pharma Reports 2017 Financial Results 23
Apr 30, 2017: NOXXON Pharma Reports 2016 Financial Results & Announces Advanced Discussions Regarding a Convertible Bond Financing 26
Corporate Communications 28
Sep 29, 2017: NOXXON Supervisory Board Elects Experienced US & EU Biotech Veteran Don deBethizy Chairman 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29
List of Figure
List of Figures
Noxxon Pharma AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Noxxon Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Noxxon Pharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Noxxon Pharma AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Noxxon Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Noxxon Pharma AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Noxxon Pharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Noxxon Pharma AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List of Table
List of Tables
Noxxon Pharma AG, Pharmaceuticals & Healthcare, Key Facts 2
Noxxon Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Noxxon Pharma AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Noxxon Pharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Noxxon Pharma AG, Deals By Therapy Area, 2012 to YTD 2018 8
Noxxon Pharma AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Noxxon Pharma Enters into Agreement with National Center for Tumor Diseases 10
NOXXON Pharma Enters into Agreement with Merck 11
Aptarion biotech Enters into Licensing Agreement with Noxxon Pharma 12
Noxxon Pharma Raises USD1 Million in Private Placement of Shares 13
Noxxon Pharma Raises USD0.4 Million in Private Placement of 7% Bond 14
Noxxon Pharma Raises USD0.6 Million in Fourth Tranche Private Placement of Bonds 15
Noxxon Pharma Raises USD0.5 Million in Third Tranche Private Placement of Bonds 16
Noxxon Pharma Raises USD0.6 Million in Second Tranche Private Placement of Bonds 17
Noxxon Pharma Raises USD1 Million in Public offering of Bonds 18
Noxxon Pharma Raises USD11 Million in Private Placement of Bonds 19
Noxxon Pharma AG, Key Competitors 20
Noxxon Pharma AG, Key Employees 21
Noxxon Pharma AG, Subsidiaries 22
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.